News & Analysis as of

HRSA Government Accountability Office Centers for Medicare & Medicaid Services (CMS)

McDermott+

McDermott+ Check-Up: September 13, 2024

McDermott+ on

House Education & the Workforce Health, Employment, Labor, and Pensions Subcommittee Holds Hearing on ERISA’s 50th Anniversary. Members and witnesses assessed how the Employee Retirement Income Security Act of 1974 (ERISA)...more

McGuireWoods Consulting

Washington Healthcare Update - June 2024

This Week in Washington: Senate Finance Committee Chairman sends letters concerning healthcare cybersecurity measures; House Energy and Commerce Committee Oversight and Investigations Subcommittee holds hearing on 340B...more

McGuireWoods Consulting

Washington Healthcare Update - May 2024 #4

This Week in Washington: Senate Finance Committee releases draft proposal outline concerning GME program; Senate HELP Committee marks up seven healthcare bills; NIH issues first-of-its-kind policy proposal to promote equal...more

Wiley Rein LLP

Recent Developments in Pharmacy-Related Legislation and Regulations

Wiley Rein LLP on

Over the last two months, there has been a steady influx of regulatory and legislative efforts regarding drug pricing and the pharmacy industry. To streamline your review, we summarize below a few noteworthy developments that...more

McGuireWoods Consulting

Washington Healthcare Update - May 2024 #2

This Week in Washington: House Ways and Means Committee marks up telehealth legislation; CMS extends state Medicaid unwinding flexibilities; Senate HELP Committee ranking member releases white paper outlining possible NIH...more

Akin Gump Strauss Hauer & Feld LLP

The Regulatory Race Is On: The Biden Administration Sprints to Issue Key Health Policies

The upcoming election, and the approaching end of the President’s four-year term, introduce additional dynamics into the agencies’ rulemaking process and even the guidance process. From now through the November election, the...more

McDermott+

The Maternal Health Crisis: What’s the Biden Administration Doing About It?

McDermott+ on

The U.S. is experiencing a maternal health crisis: it has one of the highest maternal mortality rates among high-income nations; increasing rates of complications from pregnancy or childbirth; and persistent disparities in...more

McGuireWoods Consulting

Washington Healthcare Update - May 2023

This Week in Washington: Debt Limit fight continues; Disagreements arise during Senate HELP Committee mark-up of PBM and Generic Drug Competition Bills...more

McGuireWoods Consulting

Washington Healthcare Update - January 2023

This Week in Washington: 118th Congress begins, House finally chooses Speaker...more

McGuireWoods Consulting

Washington Healthcare Update - June 2022 #2

This Week in Washington: Supreme Court Rules in Favor of 340B Hospitals, FDA Approves COVID-19 Vaccines for Children Under Five...more

McGuireWoods Consulting

Washington Healthcare Update - June 2022

This Week in Washington: House Passes FDA User Fee Reauthorization Package...more

McGuireWoods Consulting

Washington Healthcare Update - May 2022 #2

This Week in Washington: Senate Fails to Advance Bill Protecting Abortion Rights After Supreme Court Draft Opinion Leak...more

McGuireWoods Consulting

Washington Healthcare Update - March 2022 #2

This Week in Washington: Congress Passes Appropriations to Fund Government Through Fiscal Year 2023...more

McGuireWoods Consulting

Washington Healthcare Update - January 2022 #4

This Week in Washington: Senate HELP Committee Chair Patty Murray and Ranking Member Richard Burr Release Discussion Draft of Bipartisan Pandemic and Public Health Response Bill....more

McGuireWoods Consulting

Washington Healthcare Update - December 2021 #3

McGuireWoods Consulting on

This week in Washington: President Biden acknowledges that the Build Back Better Act might not pass Congress this year....more

McGuireWoods Consulting

Washington Healthcare Update - December 2021 #1

Upcoming Hearings/Markups - December 8 - House Agriculture Committee, Nutrition, Oversight, and Department Operations Subcommittee Hearing: “Review of USDA Nutrition Distribution Programs”...more

McGuireWoods Consulting

Washington Healthcare Update - May 2021 #4

This week in Washington: Talks continue on infrastructure, Senate committees moving forward on health legislation, President’s budget due the end of the week....more

McGuireWoods Consulting

Washington Healthcare Update - October 2020 #4

McGuireWoods Consulting on

This week in Washington: Mnuchin and Pelosi continue discussions for COVID-19 stimulus package....more

McGuireWoods Consulting

Washington Healthcare Update - June 2020 #4

This week in Washington: Trump administration again attempts to overturn ACA in Supreme Court, House considers legislation to shore up ACA and multiple hearings related to the COVID-19 pandemic....more

Manatt, Phelps & Phillips, LLP

340B and Medicaid: Scope, Vulnerabilities and New Survey Findings

The 340B Program’s Growing Scope - The 340B program has grown significantly in scope. According to the Health Resources and Services Administration (HRSA), as of January 1, 2018, the 340B program included 12,823 providers...more

McGuireWoods Consulting

Washington Healthcare Update - February 2020 #3

This week in Washington: The House and Senate will be in recess the week of Feb. 17 in observation of Presidents Day....more

McGuireWoods Consulting

Washington Healthcare Update - February 2020 #2

This week in Washington: Senate to hold hearing on home healthcare in rural America, House to hold hearing on protecting women's access to reproductive healthcare....more

McDermott Will & Emery

GAO Recommends CMS, HRSA Improve 340B Duplicate Discount Oversight

On January 27, the Government Accountability Office (GAO) published a report concluding that the US Department of Health and Human Services (HHS) has provided limited oversight of the 340B and Medicaid Drug Rebate Programs,...more

McGuireWoods Consulting

Washington Healthcare Update - February 2020 #1

This week in Washington: The House of Representatives passes legislation on fentanyl analogues; Senate continues impeachment trial....more

Baker Donelson

A Flurry of Recent Activity Highlights Continued Interest in 340B Program Oversight

Baker Donelson on

Four separate government releases coming over a three-week period have once again highlighted the intense interest in the 340B drug pricing program, with a federal agency and two government watchdog groups issuing guidance...more

40 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide